-
1
Amyloidosis involves abnormal amyloid protein deposition.
-
2
Dr. Tushak discusses pathology aspects.
-
3
Identification is critical for management.
-
4
An algorithm exists for patient screening.
-
5
Early diagnosis improves outcomes.
-
6
Varied management strategies are needed based on amyloidosis type.
-
7
It is classified as a rare disease.
Original Source(s)
Related Content
Masters Athletes Present Unique CV Findings
Joint clinical consensus outlines evaluation and management considerations for arrhythmias, coronary atherosclerosis, aortic dilatation, myocardial fibrosis, and related findings in older competitive athletes.
April 6, 2026
-
6 min
Surgical thoracic duct decompression: The right choice for Fontan-associated protein-losing enteropathy?
A newly published article in JTCVS Techniques presents an innovative cardiothoracic surgical approach focused on addressing a specific technical challenge while supporting efficiency and reproducibility in the operating room.
Surgical Systemic Vein Turndown For Thoracic Duct Decompression in Fontan Patients With Protein-Losing Enteropathy: Role of Multimodality Imaging
A recent American College of Cardiology expert analysis reviews surgical systemic vein (innominate vein) turndown as a promising treatment for protein?losing enteropathy (PLE) in patients with Fontan circulation.
